What DiabetOmics does
Founded in 2008, DiabetOmics operates in Health Tech industry. Initially focusing on affordable, non-invasive tests for diabetes and its complications, the company has expanded its portfolio to include a range of biomarkers for comprehensive diabetes care. DiabetOmics announced a significant development with its non-invasive testing technology gaining further traction through expanded clinical validation studies. The company has enhanced its reach by launching additional diagnostic tools targeting gestational diabetes and prediabetes. Competing with companies such as GOQii and Inito.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about DiabetOmics yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.